NCT04093128

Brief Summary

investigate beneficial effect of an herbal tea prepared from carob pulp and pods (Ceratonia siliqua), anise seed (Pimpinella Anisum L), wild thyme, green tea and eucalyptus leaves with Manuka honey (natural sweetener) on lipid profile and insulin resistance, CRP (C-reactive protein), CBC (complete blood count), liver function test, kidney function tests, inflammation and anthropometric indices in adults living in Amman Jordan

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 19, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 17, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2020

Completed
Last Updated

September 17, 2019

Status Verified

September 1, 2019

Enrollment Period

6 months

First QC Date

July 19, 2019

Last Update Submit

September 14, 2019

Conditions

Keywords

herbal teainfusioncarobgreen teaaniseinsulin resistanceinflammationhealthlipid profilemanuka honey

Outcome Measures

Primary Outcomes (18)

  • Questionnaire

    basic demographic information

    1-2 weeks

  • Homocysteine serum level

    venous blood sample for 30 candidates measured by umol/L normal range \< 12 umol/L

    7 weeks pre and post intervention

  • Fasting blood sugar

    venous blood sample for 30 candidates measured by mg/dL normal range 70-99 mg/dL

    7 weeks pre and post intervention

  • Glycosylated Haemoglobin (HBA1C) blood

    venous blood sample for 30 candidates measured by percentage normal range 4.8-5.8%

    7 weeks pre and post intervention

  • Cholesterol serum

    venous blood sample for 30 candidates measured by mg/dL normal range \<200 mg/dL

    7 weeks pre and post intervention

  • Triglyceride serum

    venous blood sample for 30 candidates measured by mg/dL normal range \<150 mg/dL

    7 weeks pre and post intervention

  • HDL cholesterol(High density lipoprotein) serum

    venous blood sample for 30 candidates measured by mg/dL normal range \>60mg/dL

    7 weeks pre and post intervention

  • Cholesterol/HDL Ratio

    venous blood sample for 30 candidates normal range \<4.0

    7 weeks pre and post intervention

  • LDL Cholesterol (low density lipoprotein) serum

    venous blood sample for 30 candidates measured by mg/dL normal range \<100mg/dL

    7 weeks pre and post intervention

  • Protein serum

    venous blood sample for 30 candidates measured by g/dL normal range 6.0-8.0g/dL

    7 weeks pre and post intervention

  • C-Reactive Protein high sensitivity serum

    venous blood sample for 30 candidates measured by mg/dL , low risk of CVD \<1.0 mg/dL

    7 weeks pre and post intervention

  • Insulin serum

    venous blood sample for 30 candidates measured by uU/ml normal range 2.6-24.9

    7 weeks pre and post intervention

  • Cortisol Total (AM) serum

    venous blood sample for 30 candidates measured by ug/dL normal range 6.02-18.4

    7 weeks pre and post intervention

  • Tumor Necrosis Factor

    venous blood sample for 30 candidates measured by pg/mL normal range upto 8.1

    7 weeks pre and post intervention

  • 8-OH-2 Desoxyyguanosine urine

    Urine sample measured by micromol/mol normal range 0.1-2.4

    7 weeks pre and post intervention

  • interleukin 1 Beta

    venous blood sample for 30 candidates measured by pg/ml normal range upto 5 pg/ml

    7 weeks pre and post intervention

  • weight

    measured on inbody 770 measured by kg

    7 weeks pre and post intervention

  • Height

    measured by cm

    pre intervention

Secondary Outcomes (31)

  • gastrointestinal symptoms questionnaire

    7 weeks pre and post intervention

  • Creatinine serum

    7 weeks pre and post intervention

  • Alanine Aminotransferase (ALT/GPT) serum

    7 weeks pre and post intervention

  • Aspartate Aminotransferase (AST/GOT) serum

    7 weeks pre and post intervention

  • Gamma-Glutamyl Transferase (GGT) serum

    7 weeks pre and post intervention

  • +26 more secondary outcomes

Study Arms (1)

adults aged 19-57

EXPERIMENTAL

adults aged 19-57 years old living in Amman Jordan, body mass index between 19-57

Other: herbal tea intervention

Interventions

herbal tea intervention for 7 weeks

Also known as: herbal tea, carob, anise, green tea, manuka honey, wild thyme, eucalyptus leaves
adults aged 19-57

Eligibility Criteria

Age19 Years - 57 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • adults aged 19-57 years
  • male to female ratio (1:1 ratio)
  • BMI 19-35 kg/m2
  • Currently living in Amman
  • without significant apparent diseases
  • Able to drink the tested herbal tea twice a day

You may not qualify if:

  • Have chronic diseases such as diabetes, hypertension, cardiovascular or endocrine diseases or disabilities
  • Using medical drugs and/or supplements
  • Below 19 or above 57 years.
  • participation in clinical trials within the last 2 months
  • use of lipid-lowering drugs, or diabetic medication.
  • Lactating and pregnant women will be also excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ruba Musharbash

Amman, Jordan

Location

MeSH Terms

Conditions

Insulin ResistanceInflammation

Interventions

Teas, Herballocust bean gumanise oilTea

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Plant PreparationsBiological ProductsComplex MixturesBeveragesDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

July 19, 2019

First Posted

September 17, 2019

Study Start

June 1, 2019

Primary Completion

November 30, 2019

Study Completion

January 30, 2020

Last Updated

September 17, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will not share

Locations